ANTHIM (OBILTOXAXIMAB) — FDA Approval BLA125509 (ELUSYS THERAPEUTICS INC)
ANTHIM (OBILTOXAXIMAB) — FDA Approval BLA125509 (ELUSYS THERAPEUTICS INC) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: ANTHIM; Active ingredients: OBILTOXAXIMAB; Application number: BLA125509.
| Brand name | ANTHIM |
|---|---|
| Active ingredients | OBILTOXAXIMAB |
| Application number | BLA125509 |
| Sponsor | ELUSYS THERAPEUTICS INC |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20160318 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →